Key Laboratory of Analytical Chemistry for Biology and Medicine (Ministry of Education), College of Chemistry and Molecular Sciences , Wuhan University , Wuhan , 430072 , People's Republic of China.
Anal Chem. 2019 Aug 6;91(15):10172-10179. doi: 10.1021/acs.analchem.9b02181. Epub 2019 Jul 19.
Extracellular vesicles (EVs) have emerged as promising tumor biomarkers for early cancer diagnosis, as primary tumor-secreted EVs carry characteristic molecular information on parent cells. It is thus desirable to realize the efficient discrimination of the signatured EVs-associated microRNAs (miRNAs) with low expression and subtle variation. Here, we introduce an autonomous nonlinear enzyme-free signal amplification paradigm for EVs discrimination through a highly sensitive and selective detection of their inherent miRNAs in situ. Our proposed amplifier consists of a modularized DNAzyme-amplified two-stage cascaded hybridization chain reaction (CHCR-DNAzyme) circuit, where the analyte-generated output of the preceding hybridization chain reaction (HCR1) stage serves as input to motivate the following hybridization chain reaction (HCR2) stage and the concomitant assembly of numerous DNAzyme biocatalysts. By incorporating a flexibly configurable sensing module, this modular CHCR-DNAzyme circuit can further extend to "plug-and-play" sensing mode that enables the miRNA assay with high specificity. The sophisticated design and the detecting performance of our CHCR-DNAzyme scheme were systematically investigated in vitro. The optimized CHCR-DNAzyme system was further applied for distinguishing EVs derived from different cells through the amplified detection of a putative miRNA biomarker in EVs. This compact CHCR-DNAzyme amplifier provides a universal and facile toolbox for highly efficient identification of multiple miRNAs-involved EVs and thus holds great potential for early cancer diagnosis.
细胞外囊泡 (EVs) 已成为早期癌症诊断有前途的肿瘤生物标志物,因为原发性肿瘤分泌的 EVs 携带有关母细胞的特征分子信息。因此,理想情况下,需要实现对低表达和微小变化的特征化 EV 相关 microRNA (miRNA) 的有效区分。在这里,我们通过在原位高度敏感和选择性地检测其内在 miRNA,引入了一种用于 EV 区分的自主非线性无酶信号放大范例。我们提出的放大器由模块化的酶放大两阶段级联杂交链式反应 (CHCR-DNAzyme) 电路组成,其中前杂交链式反应 (HCR1) 阶段的分析物生成输出作为输入来激发后续杂交链式反应 (HCR2) 阶段和伴随的大量 DNAzyme 生物催化剂的组装。通过纳入灵活可配置的传感模块,这种模块化的 CHCR-DNAzyme 电路可以进一步扩展到“即插即用”传感模式,从而实现 miRNA 测定的高特异性。我们系统地研究了 CHCR-DNAzyme 方案的复杂设计和检测性能。在体外进一步应用优化的 CHCR-DNAzyme 系统通过放大 EV 中推定的 miRNA 生物标志物来区分来自不同细胞的 EV。这种紧凑的 CHCR-DNAzyme 放大器为高效识别多种涉及 miRNA 的 EV 提供了通用且简便的工具包,因此在早期癌症诊断中具有很大的潜力。